Takahashi, Hirokazu

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Yamamura, S., Eslam, M., Kawaguchi, T., Tsutsumi, T., Nakano, D., Yoshinaga, S., Takahashi, H., Anzai, K., George, J., & Torimura, T. (2020) · Liver International

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 401

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH

Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 294

Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis # †

Fujita, K., Nozaki, Y., Wada, K., Yoneda, M., Fujimoto, Y., Fujitake, M., Endo, H., Takahashi, H., Inamori, M., Kobayashi, N., et al. (2009) · Hepatology

Liver Disease Diagnosis and TreatmentLipid metabolism and disorders

Cited by 244

TGF-β2 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism

Takahashi, H., Alves, C. R. R., Stanford, K. I., Middelbeek, R. J. W., Nigro, P., Ryan, R. E., Xue, R., Sakaguchi, M., Lynes, M. D., So, K., et al. (2019) · Nature Metabolism

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 204

Metformin suppresses intestinal polyp growth in Apc Min/+ mice

Tomimoto, A., Endo, H., Sugiyama, M., Fujisawa, T., Hosono, K., Takahashi, H., Nakajima, N., Nagashima, Y., Wada, K., Nakagama, H., et al. (2008) · Cancer Science

Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancer

Cited by 185

Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD

Takahashi, H., Kessoku, T., Kawanaka, M., Nonaka, M., Hyogo, H., Fujii, H., Nakajima, T., Imajo, K., Tanaka, K., Kubotsu, Y., et al. (2022) · Hepatology Communications

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 153

Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease

Imajo, K., Honda, Y., Kobayashi, T., Nagai, K., Ozaki, A., Iwaki, M., Kessoku, T., Ogawa, Y., Takahashi, H., Saigusa, Y., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentUltrasound Imaging and Elastography

Cited by 140

A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease

Younossi, Z. M., Ong, J. P., Takahashi, H., Yilmaz, Y., Eguc`hi, Y., El Kassas, M., Buti, M., Diago, M., Zheng, M.-H., Fan, J.-G., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 115

Maternal Exercise Improves Glucose Tolerance in Female Offspring

Stanford, K. I., Takahashi, H., So, K., Alves-Wagner, A. B., Prince, N. B., Lehnig, A. C., Getchell, K. M., Lee, M.-Y., Hirshman, M. F., & Goodyear, L. J. (2017) · Diabetes

Birth, Development, and HealthGestational Diabetes Research and Management

Cited by 114

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms

Takahashi, H., Kotani, K., Tanaka, K., Egucih, Y., & Anzai, K. (2018) · Frontiers in Endocrinology

Liver Disease Diagnosis and TreatmentExercise and Physiological Responses

Cited by 55

Effect modification by geographic area on the association between health literacy and self-rated health: A nationwide cross-sectional study in Japan

Ishikawa, H., Ogawa, R., Otsuki, A., Saito, J., Yaguchi-Saito, A., Kuchiba, A., Fujimori, M., Fukuda, Y., Shimazu, T., INFORM Study Group, et al. (2023) · BMC Public Health

Health Literacy and Information AccessibilityHealth disparities and outcomes

Cited by 14